Quantification of Extracellular and Intracellular Adenosine Production
- 20 April 1999
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation
- Vol. 99 (15), 2041-2047
- https://doi.org/10.1161/01.cir.99.15.2041
Abstract
Background —Inhibitors of adenosine membrane transport cause vasodilation and enhance the plasma adenosine concentration. However, it is unclear why the plasma adenosine concentration rises rather than falls when membrane transport is inhibited. We tested the hypothesis that the cytosolic adenosine concentration exceeds the interstitial concentration under well-oxygenated conditions. Methods and Results —In isolated, isovolumically working guinea pig hearts (n=50), the release rate of adenosine and accumulation of S -adenosylhomocysteine (after 20 minutes of 200 μmol/L homocysteine), a measure of the free cytosolic adenosine concentration, were determined in the absence and presence of specific and powerful blockers of adenosine membrane transport (nitrobenzylthioinosine 1 μmol/L), adenosine deaminase (erythro-9-hydroxy-nonyl-adenine 5 μmol/L), and adenosine kinase (iodotubericidine 10 μmol/L). Data analysis with a distributed multicompartment model revealed a total cardiac adenosine production rate of 2294 pmol · min −1 · g −1 , of which 8% was produced in the extracellular region. Because of a high rate of intracellular metabolism, however, 70.3% of extracellularly produced adenosine was taken up into cellular regions, an effect that was effectively eliminated by membrane transport block. The resulting ≈2.8-fold increase of the interstitial adenosine concentration evoked near-maximal coronary dilation. Conclusions —We rejected the hypothesis that the cytosolic adenosine concentration exceeds the interstitial. Rather, there is significant extracellular production, and the parenchymal cell represents a sink, not a source, for adenosine under well-oxygenated conditions.This publication has 11 references indexed in Scilit:
- The multidrug resistance (mdr1) gene product functions as an ATP channel.Proceedings of the National Academy of Sciences of the United States of America, 1993
- Inhibition of adenosine metabolism increases myocardial interstitial adenosine concentrations and coronary flowJournal of Molecular and Cellular Cardiology, 1992
- Contribution of S-adenosylhomocysteine to cardiac adenosine formationJournal of Molecular and Cellular Cardiology, 1989
- Turnover of adenosine in plasma of human and dog bloodAmerican Journal of Physiology-Cell Physiology, 1989
- New Insights into the Mechanism of Myocardial Adenosine FormationPublished by Springer Science and Business Media LLC ,1987
- Drug Interactions with Nucleoside Transport SystemsPublished by Springer Science and Business Media LLC ,1987
- Contribution of coronary endothelial cells to cardiac adenosine productionPflügers Archiv - European Journal of Physiology, 1986
- Effects of pacing-induced myocardial ischemia on hypoxanthine efflux from the human heartThe American Journal of Cardiology, 1977
- Einfluß von herz- und gefäßwirksamen Substanzen auf die Aktivität der PhosphodiesteraseNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1969
- Kompetitive Hemmung der Adenosin-Desaminase als mögliche Ursache der coronardilatierenden Wirkung einer Pyrimidopyrimidin-VerbindungNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1966